Start Date
December 31, 2014
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Oprozomib
Study subjects will receive oprozomib tablets once a day on Days 1, 2, 8, 9, 15, 16, 22 and 23 of a 28 day cycle
Sorafenib
Study subjects will receive sorafenib tablets twice a day for Days 1-28
Lahey Hospital & Medical Center, Burlington
Rocky Mountain Cancer Centers, Denver
University of Miami Hospital & Clinics, Miami
The University of Chicago Medical Center, Chicago
The Ohio State University, Martha Morehouse Medical Plaza, Columbus
University of Wisconsin Comprehensive Cancer Center, Madison
Lead Sponsor
Amgen
INDUSTRY